Related Experiment Video

Updated: Mar 24, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma

Ling Chen1,2, Guangming Kong3, Chuantao Zhang1

  • 1Department of Oncology, Affiliated Hospital of Qingdao University, Qingdao, China.

Oncotarget
|March 5, 2016
PubMed

Insights

MicroRNA-432 (miR-432) is downregulated in lung adenocarcinoma (LAD), correlating with advanced stages and poor prognosis. Restoring miR-432 inhibits LAD cell proliferation and enhances cisplatin sensitivity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung adenocarcinoma (LAD) is characterized by abnormal proliferation and drug resistance, leading to low survival rates.
  • MicroRNAs (miRNAs) are key regulators of pathological mechanisms in cancer.
  • The role of miR-432 in LAD progression and treatment response requires further elucidation.

Purpose of the Study:

  • To investigate the expression patterns of miR-432 in LAD tissues.
  • To explore the functional impact of miR-432 on LAD cell proliferation and cisplatin sensitivity.
  • To identify the molecular targets and mechanisms underlying miR-432's function in LAD.

Main Methods:

  • Quantitative analysis of miR-432 expression in LAD tissues and correlation with clinical parameters.
  • In vitro experiments assessing the effects of miR-432 overexpression on cell proliferation, cell cycle, and cisplatin sensitivity.
  • Bioinformatic analysis and experimental validation to identify direct targets of miR-432 (E2F3 and AXL).

Main Results:

  • Downregulation of miR-432 in LAD tissues was significantly associated with higher clinical stage and poorer prognosis.
  • miR-432 expression negatively correlated with Ki67 labeling index, indicating reduced proliferation.
  • Overexpression of miR-432 suppressed LAD cell proliferation, induced cell cycle arrest, and sensitized cells to cisplatin.
  • miR-432 directly targets E2F3 and AXL, which mediate its effects on proliferation and drug sensitivity.
  • miR-432 levels were inversely correlated with E2F3 and AXL levels in human LAD tissues.

Conclusions:

  • miR-432 acts as a tumor-suppressive miRNA in lung adenocarcinoma.
  • miR-432 downregulation is linked to LAD progression and chemoresistance.
  • miR-432 holds potential as a prognostic biomarker and a therapeutic target for LAD.
Keywords:
AXLE2F3lung adenocarcinomamiR-432

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

12.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K